David Tuller

Trial By Error: Losers in NICE Guideline Fight Remain Defiant Despite Public Repudiation of Their Claims

By David Tuller, DrPH *For more about the significance of the new NICE guideline for ME/CFS, the blog ME/CFS Skeptic has this excellent summary. Also, psychologist Brian Hughes covers the deep concerns of leading medical groups that the guideline recommends against the Lightning Process. It is not surprising that esteemed ...

Trial By Error: NICE Liberates New ME/CFS Guideline After Two-Month Hijacking Nightmare

By David Tuller, DrPH After much drama, the National Institute for Health and Care Excellence (NICE) has finally liberated its hijacked ME/CFS clinical guideline. As many know, in August the agency abruptly called off the planned publication of this new document, which was developed over four years. This decision occurred ...

Trial By Error: PACE Authors Now Blame “Misunderstandings” for GET/CBT Criticisms

By David Tuller, DrPH It is hard to know what to make of the news that a peer-reviewed journal has actually accepted a PACE-reunion paper from the three lead investigators, Professors Michael Sharpe, Trudie Chalder, and Peter White. Even more so for a paper titled--without irony, it seems--"Evidence based care ...

Trial By Error: NICE Announces Upcoming Release of ME/CFS Guideline After Prolonged Hostage Drama

By David Tuller, DrPH Two days following a high-profile meeting with opponents and supporters of its new-but-still-unpublished ME/CFS guideline, the UK's National Institute for Health and Care Excellence announced on Wednesday that it plans to release the document next week. The decision comes after a powerful cabal of medical practitioners ...

Trial By Error: Advocates Issue Hopeful Comments After NICE Pow-Wow on ME/CFS Guideline

By David Tuller, DrPH Two months ago, the UK's National Institute for Health and Care Excellence (NICE) abruptly delayed publication of its new ME/CFS clinical guideline under fierce objections from the GET/CBT ideological brigades and their minions. Today (Monday, October 18th), the agency hosted a meeting to allow these powerful ...
Scroll to Top